REVERSAL OF GALLIUM ARSENIDE-INDUCED SUPPRESSION OF THE ANTIBODY-FORMING CELL RESPONSE BY VEHICLE SUPERNATANTS .2. NATURE AND IDENTIFICATION OF REVERSING FACTORS
La. Burns et Ae. Munson, REVERSAL OF GALLIUM ARSENIDE-INDUCED SUPPRESSION OF THE ANTIBODY-FORMING CELL RESPONSE BY VEHICLE SUPERNATANTS .2. NATURE AND IDENTIFICATION OF REVERSING FACTORS, The Journal of pharmacology and experimental therapeutics, 265(1), 1993, pp. 150-184
Previous studies have demonstrated that several immunological events w
hich are T cell mediated are significantly suppressed by a single expo
sure to gallium arsenide (GaAs). In addition, in the in vitro-generate
d antibody-forming cell (AFC) response supernatants from vehicle (VH)
cultures were able to time-dependently reverse suppression induced by
either in vivo (200 mg/kg) or in vitro (50 muM) exposure to GaAs. The
present studies were designed to determine the nature and identificati
on of the reversing factors present in VH supernatants. VH supernatant
s (25-100%) were able to dose-dependently reverse suppression of the A
FC response (from 45% suppression to 48% enhancement of the VH respons
e) induced by GaAs exposure (200 mg/kg). Concentration of 24-hr VH sup
ernatants and treatment with proteinases revealed that the reversing f
actors were protein in nature with a molecular weight between 5,000 an
d 50,000 Da. This molecular weight range encompasses many of the lymph
okines known to be necessary for the generation of an immune response.
In antibody cultures exposed either in vivo or in vitro to VH or GaAs
, HT-2 bioassay and antigen capture enzyme-linked immunosorbent assays
demonstrated that GaAs exposure alters production of interleukin (IL)
-2, IL-4, IL-5 and IL-6. Interestingly, the alterations in lymphokine
production differed between the exposure regimes. Direct addition of I
L-2 to antibody cultures resulted in a dose-dependent (6.25-50 ng/ml)
reversal of GaAs-induced suppression (in vivo exposure) and was also d
ependent on the concentration of GaAs (50-200 mg/kg). IL-4 suppressed
the VH AFC response and failed to reverse GaAs suppression. This VH su
ppression was a result of a class switch from immunoglobulin M to immu
noglobulin G1. Both IL-5 and IL-6 were able to reverse GaAs-induced su
ppression, but these effects were not dose related. Anti-IL-5 antibody
had no effect on the VH AFC response or the GaAs-induced immunosuppre
ssion. In summary, these data indicate that the factors in VH supernat
ants which reverse GaAs immunosuppression are protein in nature with m
olecular weights between 5,000 and 50,000 Da. GaAs exposure altered pr
oduction of all lymphokines evaluated; however, it would appear from t
hese and previous data that IL-2 is a primary target for GaAs after in
vivo exposure.